Overcoming Barriers to International Clinical Trials for Rare Cancers
Friday, December 10, 2010
The goals of this conference were to introduce key institutional players to the topic of international clinical trials in rare cancers and to establish an ongoing dialogue. Participants left the meeting with a set of specific priorities that need to be enacted to promote these trials. The meeting promoted consensus on the way that resources are prioritized to address rare cancers. Participants were asked to convey the content of the meeting to their constituencies and to follow up with pilot concepts.
Jack Welch, M.D., Ph.D., email@example.com firstname.lastname@example.org
National Cancer Institute
Office of Rare Diseases Research
From the National Center for Advancing Translational Sciences
From the National Institutes of Health